United States Suboxone Market Is Anticipated To Witness High Growth Owing To Increasing Opioid Addiction

 


The United States suboxone market is the largest hub for opioid addiction medication. Suboxone, which contains buprenorphine and naloxone, is commonly prescribed to treat patients with opioid addiction by curbing cravings and withdrawal symptoms. It provides an alternative to methadone for medication-assisted treatment of opioid use disorder.

Suboxone is available in the form of sublingual films and tablets. The need for effective treatment of opioid addiction has been growing in the country owing to rising rates of opioid overdose deaths. This has fueled the demand for substitution medication like Suboxone.

The United States of America Suboxone Market is estimated to be valued at US$ 2,285.5 Mn in 2024 and is expected to exhibit a CAGR of 4.1% over the forecast period 2024-2031.

Key Takeaways

Key players operating in the United States suboxone market are Indivior PLC., Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals LLC., Mylan N.V., Novartis AG, Teva Pharmaceutical Industries Ltd., Mallinckrodt, Lannett Co Inc., Sun Pharmaceutical Industries Ltd., and Alkem Labs. Indivior PLC holds the majority market share with their branded Suboxone film and tablet formulations.

The opioid crisis in the US has opened up opportunities for manufacturers to develop newer suboxone formulations with improved convenience and compliance. Sublingual films have gained popularity over tablets due to their easier administration. Extended-release formulations are being researched to provide medication for weekly or monthly use.

Major players are focused on expanding their geographic presence across states in the US to strengthen market access. Companies are also looking at potential mergers and acquisitions to complement their product portfolios. Partnerships with clinics and healthcare facilities can help optimise suboxone distribution channels.

Market Drivers

The growing problem of prescription opioid abuse and overdose deaths is a key factor driving the US suboxone market. According to CDC reports, over 450,000 people died from overdoses involving prescription or illicit opioids between 2000-2018. This has boosted the uptake of medication-assisted treatment using suboxone.

Favorable regulatory policies related to opioid addiction have encouraged adoption of suboxone as a treatment option. The Affordable Care Act and Medicaid expansion have improved insurance coverage for medications like suboxone, making treatment more affordable.

Market Restraints

Misuse and diversion of buprenorphine medication remain a challenge hampering the suboxone market growth. There is a risk of suboxone being misused by people without prescription or for getting high. This has led authorities to tighten dispensing policies for buprenorphine drugs.

Limited availability of healthcare providers educated on medication-assisted therapy acts as another bottleneck. Only few physicians complete necessary training to prescribe schedule III drugs like buprenorphine. This causes treatment gaps especially in rural areas.

Segment Analysis

The United States of America Suboxone market is segmented into sublingual films and tablets. The sublingual films segment dominates the market owing to higher convenience and better adherence to treatment compared to tablets. The convenience of sublingual films and once daily dosing drives adoption.

Global Analysis

Regionally, the North America region holds the largest share in the United States of America Suboxone market due to growing opioid addiction and availability of favorable reimbursement policies for addiction treatment. The U.S. contributes significantly owing to the high prevalence of opioid use disorder and increasing initiatives to curb the opioid crisis. The market exhibits steady growth in the U.S. on account of rising research on new formulations and generic entry post patent expiry of branded Suboxone.

Get more insights on this topic:  https://www.ukwebwire.com/united-states-of-america-suboxone-market-estimated-to-witness-high-growth-owing-to-increasing-addiction-rates/

 

Author Bio

Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups. (LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)

What Are The Key Data Covered In This United States Of America Suboxone  Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the United States Of America Suboxone 's growth between 2024 and 2031.

:- Accurate calculation of the size of the United States Of America Suboxone  and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- United States Of America Suboxone  Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of United States Of America Suboxone  vendors

FAQ’s

Q.1 What are the main factors influencing the United States Of America Suboxone ?

Q.2 Which companies are the major sources in this industry?

Q.3 What are the market’s opportunities, risks, and general structure?

Q.4 Which of the top United States Of America Suboxone  companies compare in terms of sales, revenue, and prices?

Q.5 Which businesses serve as the United States Of America Suboxone ’s distributors, traders, and dealers?

Q.6 How are market types and applications and deals, revenue, and value explored?

Q.7 What does a business area’s assessment of agreements, income, and value implicate?

Comments

Post a Comment

Popular posts from this blog

Space Economy : Global Space Economy Enters New Phase of Growth and Innovation

Image
The Growing Global Space Economy As these new commercial applications and models emerge in fields like earth observation, communications, infrastructure development and utilization of space resources, the global space economy is expanding rapidly. Reports from leading analyst firms project significant growth rates over the coming decade, with an estimated total global space economy size exceeding a trillion dollars by 2040. Private capital investment in space has also grown 10-fold over the past decade to well over $5 billion in 2021 alone. As more commercial activity accelerates in low-Earth orbit and beyond, global cooperation will play a vital role in management of issues like orbital traffic, spectrum allocation and safety standards. International organizations like the United Nations are developing cooperation frameworks to ensure the responsible governance of these emerging space industries and exploration activities. Overall, the expanding range of commercial uses of space
Read more

Luxury Vegan Handbags: The Surge In Popularity Of High-End Vegan Handbags A New Trend In Sustainable Fashion

Image
  As consumer consciousness around sustainability and animal welfare grows, more luxury brands are introducing   vegan handbag   lines that are just as stylish and durable as traditional leather bags but without the environmental or ethical downsides. By using innovative materials derived from plants, these eco-friendly luxury bags allow fashionistas to feel good about what they carry. Pioneering brands like Matt & Nat, Will’s Vegan Store, and Veja are leading the way in offering luxury vegan styles that can rival even the most prestigious designer labels. Materials Of The Future Manufacturers are developing premium vegan materials that are indistinguishable from leather both in look and feel. Pineapple leather and mushroom leather, for example, are made from the waste fiber of pineapples and mycelium cells from mushrooms, respectively. These innovative materials have a luxurious texture, last for years, and biodegrade completely without harming the environment. Additional popular
Read more

United States Pharmaceuticals Market is Anticipated to Witness High Growth Owing to Growing Geriatric Population

Image
  The United States pharmaceuticals market consists of prescription and over-the-counter drugs sold in the country. Pharmaceuticals are used in prevention, diagnosis, treatment and mitigation of diseases. The growing geriatric population which is more susceptible to chronic diseases and increasing research and development spending by pharmaceutical companies are amongst the key factors driving the growth of this market. The United States pharmaceuticals Market is estimated to be valued at  US$ 599.47 Bn in   2024  and is expected to exhibit a  CAGR of 8.6%  over the forecast period 2024–2031. Key Takeaways Key players operating in the United States pharmaceuticals  are Johnson & Johnson, Pfizer, AbbVie, Merck, Bristol-Myers Squibb, Amgen, Eli Lilly, Novartis.  These players are undertaking various strategic initiatives such as partnerships, mergers & acquisitions and new product launches to gain competitive advantage and strengthen their foothold in the market. The  United Stat
Read more